212 related articles for article (PubMed ID: 1968051)
1. Overexpression of the mdr1 gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin-A.
Nooter K; Sonneveld P; Oostrum R; Herweijer H; Hagenbeek T; Valerio D
Int J Cancer; 1990 Feb; 45(2):263-8. PubMed ID: 1968051
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia.
Ross DD; Wooten PJ; Sridhara R; Ordóñez JV; Lee EJ; Schiffer CA
Blood; 1993 Aug; 82(4):1288-99. PubMed ID: 8102561
[TBL] [Abstract][Full Text] [Related]
3. Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine.
Herweijer H; Sonneveld P; Baas F; Nooter K
J Natl Cancer Inst; 1990 Jul; 82(13):1133-40. PubMed ID: 1972761
[TBL] [Abstract][Full Text] [Related]
4. Reversal of drug-resistance by cyclosporin-A in a patient with acute myelocytic leukaemia.
Sonneveld P; Nooter K
Br J Haematol; 1990 Jun; 75(2):208-11. PubMed ID: 2372507
[TBL] [Abstract][Full Text] [Related]
5. Prolongation of medium exchange is associated with a decrease in function but not expression of the P-glycoprotein pump in leukaemic cells.
Hegewisch-Becker S; Faltz C; Hossfeld DK
Eur J Haematol; 1996; 56(1-2):12-22. PubMed ID: 8599988
[TBL] [Abstract][Full Text] [Related]
6. Expression of the mdr3 gene in prolymphocytic leukemia: association with cyclosporin-A-induced increase in drug accumulation.
Nooter K; Sonneveld P; Janssen A; Oostrum R; Boersma T; Herweijer H; Valerio D; Hagemeijer A; Baas F
Int J Cancer; 1990 Apr; 45(4):626-31. PubMed ID: 2323839
[TBL] [Abstract][Full Text] [Related]
7. The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia.
den Boer ML; Pieters R; Kazemier KM; Janka-Schaub GE; Henze G; Veerman AJ
Leukemia; 1998 Jun; 12(6):912-20. PubMed ID: 9639420
[TBL] [Abstract][Full Text] [Related]
8. Correlation of MDR1/P-170 expression with daunorubicin uptake and sensitivity of leukemic progenitors in acute myeloid leukemia.
Campos L; Guyotat D; Jaffar C; Solary E; Archimbaud E; Treille D
Eur J Haematol; 1992 May; 48(5):254-8. PubMed ID: 1353726
[TBL] [Abstract][Full Text] [Related]
9. Different effects of metabolic inhibitors and cyclosporin A on daunorubicin transport in leukemia cells from patients with AML.
Knaust E; Porwit-MacDonald A; Gruber A; Xu D; Peterson C
Leuk Res; 2003 Feb; 27(2):183-91. PubMed ID: 12526924
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance phenotype in leukaemic cells from patients with acute myelocytic leukaemia can be detected with 99Tc(m)-MIBI.
Gruber A; Areström I; Xu D; Liliemark J; Larsson SA; Jacobsson H
Br J Cancer; 1998 Jun; 77(11):1732-6. PubMed ID: 9667640
[TBL] [Abstract][Full Text] [Related]
11. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y
Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
[TBL] [Abstract][Full Text] [Related]
12. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia.
Ho MM; Hogge DE; Ling V
Exp Hematol; 2008 Apr; 36(4):433-42. PubMed ID: 18249061
[TBL] [Abstract][Full Text] [Related]
13. Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression.
Marie JP; Faussat-Suberville AM; Zhou D; Zittoun R
Leukemia; 1993 Jun; 7(6):825-31. PubMed ID: 8099135
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric assessment of multidrug resistance (MDR) phenotype in acute myeloid leukaemia.
Hart SM; Ganeshaguru K; Lyttelton MP; Prentice HG; Hoffbrand AV; Mehta AB
Leuk Lymphoma; 1993 Oct; 11(3-4):239-48. PubMed ID: 7903178
[TBL] [Abstract][Full Text] [Related]
15. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
Mankhetkorn S; Garnier-Suillerot A
Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
[TBL] [Abstract][Full Text] [Related]
16. P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemia.
Tidefelt U; Liliemark J; Gruber A; Liliemark E; Sundman-Engberg B; Juliusson G; Stenke L; Elmhorn-Rosenborg A; Möllgård L; Lehman S; Xu D; Covelli A; Gustavsson B; Paul C
J Clin Oncol; 2000 May; 18(9):1837-44. PubMed ID: 10784624
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation.
Wang YH; Imai Y; Shiseki M; Tanaka J; Motoji T
Leuk Res; 2018 Apr; 67():99-108. PubMed ID: 29482174
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric study of idarubicin and daunorubicin accumulation and the effect of verapamil in leukemic cell lines and fresh cells from patients with acute non-lymphoblastic leukemia.
Boiron JM; Belloc F; Montastruc M; Cony-Makhoul P; Dumain P; Marit G; Mahon FX; Puntous M; Lopez F; Lacombe F
Leuk Res; 1994 May; 18(5):313-8. PubMed ID: 8182921
[TBL] [Abstract][Full Text] [Related]
19. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines.
Bailly JD; Muller C; Jaffrézou JP; Demur C; Gassar G; Bordier C; Laurent G
Leukemia; 1995 May; 9(5):799-807. PubMed ID: 7769842
[TBL] [Abstract][Full Text] [Related]
20. Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts.
Pallis M; Turzanski J; Langabeer S; Russell NH
Adv Exp Med Biol; 1999; 457():77-88. PubMed ID: 10500783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
